Atlas Trials

Evaluation of Repeat Administration of Purified Poloxamer 188

Clinical trial NCT02449616 · COMPLETED

Trial details

NCT number
NCT02449616
Sponsor
Mast Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2015-06-01
Primary completion
2016-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.